![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Rex Medical’s Peripheral Atherectomy Device Cleared
Rex Medical’s Peripheral Atherectomy Device Cleared
September 16, 2019
The FDA granted 510(k) clearance to Rex Medical’s Revolution peripheral atherectomy system, a device designed to remove blood clots from peripheral arteries of patients with atherosclerosis.
The device has multiple above and below-the-knee uses, including for multiple plaque forms ranging from clots and soft plaque to severely calcified lesions.
The system uses a 72-watt power supply similar to a laptop charger, requires no capital equipment and minimal set up time, the company said.
Upcoming Events
-
21Oct